We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$96.2B
AUM Growth
+$13.8B
Cap. Flow
+$2.5B
Cap. Flow %
2.6%
Top 10 Hldgs %
19.24%
Holding
5,235
New
767
Increased
1,692
Reduced
1,826
Closed
817

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$410M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$308M
3
LLY icon
Eli Lilly
LLY
+$292M
4
COST icon
Costco
COST
+$291M
5
F icon
Ford
F
+$257M

Sector Composition

Rank Sector Weight
1 Technology 10.55%
2 Consumer Discretionary 7.1%
3 Financials 4.87%
4 Healthcare 4.79%
5 Industrials 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPO icon
2301
Enpro
NPO
$6.63B
$1.51M ﹤0.01%
+7,899
New +$1.35M
CADE
2302
DELISTED
Cadence Bank
CADE
$1.51M ﹤0.01%
47,238
-91,058
-66% -$2.73M
SPXC icon
2303
SPX Corp
SPXC
$10.2B
$1.51M ﹤0.01%
9,000
-48,409
-84% -$7.09M
RL icon
2304
CALL
Ralph Lauren
RL
$22.5B
$1.51M ﹤0.01%
5,500
-3,700
-40% -$916K
EXTR icon
2305
Extreme Networks
EXTR
$3.92B
$1.5M ﹤0.01%
83,322
+16,857
+25% +$248K
HNRG icon
2306
Hallador Energy
HNRG
$689M
$1.49M ﹤0.01%
94,355
+66,691
+241% +$1.03M
FIVE icon
2307
Five Below
FIVE
$11.5B
$1.49M ﹤0.01%
11,384
+6,173
+118% +$601K
DOG
2308
ProShares Short Dow30
DOG
$109M
$1.49M ﹤0.01%
58,603
+32,283
+123% +$878K
TEVA icon
2309
Teva Pharmaceuticals
TEVA
$36.9B
$1.49M ﹤0.01%
89,060
-576,737
-87% -$9.31M
IMMR icon
2310
Immersion
IMMR
$254M
$1.49M ﹤0.01%
188,988
+25,455
+16% +$189K
INDB icon
2311
Independent Bank
INDB
$4.1B
$1.49M ﹤0.01%
+23,636
New +$1.44M
MSEX icon
2312
Middlesex Water
MSEX
$1.08B
$1.48M ﹤0.01%
27,380
+11,929
+77% +$706K
BLFS icon
2313
BioLife Solutions
BLFS
$1.56B
$1.48M ﹤0.01%
+68,809
New +$1.55M
FOUR icon
2314
Shift4
FOUR
$4.35B
$1.48M ﹤0.01%
14,906
-275,869
-95% -$24.1M
STC icon
2315
Stewart Information Services
STC
$2.11B
$1.48M ﹤0.01%
22,679
+15,299
+207% +$983K
IOVA icon
2316
Iovance Biotherapeutics
IOVA
$2.1B
$1.47M ﹤0.01%
856,569
+458,540
+115% +$1.14M
CRSP icon
2317
CRISPR Therapeutics
CRSP
$4.68B
$1.47M ﹤0.01%
30,278
-42,746
-59% -$1.65M
WTW icon
2318
PUT
Willis Towers Watson
WTW
$29.9B
$1.47M ﹤0.01%
+4,800
New +$1.49M
PRCH icon
2319
Porch Group
PRCH
$1.38B
$1.47M ﹤0.01%
124,693
+68,326
+121% +$587K
UCB
2320
United Community Banks
UCB
$4.27B
$1.47M ﹤0.01%
+49,280
New +$1.37M
CSW
2321
CSW Industrials
CSW
$4.87B
$1.47M ﹤0.01%
5,116
-3,727
-42% -$1.13M
VKTX icon
2322
Viking Therapeutics
VKTX
$3.93B
$1.47M ﹤0.01%
55,355
-383,576
-87% -$10.1M
HLT icon
2323
PUT
Hilton Worldwide
HLT
$73.4B
$1.46M ﹤0.01%
5,500
+1,400
+34% +$333K
UPBD icon
2324
Upbound Group
UPBD
$1.26B
$1.46M ﹤0.01%
+58,279
New +$1.36M
GLOB icon
2325
PUT
Globant
GLOB
$1.52B
$1.46M ﹤0.01%
+16,100
New +$1.72M

Similar funds

Squarepoint's Q2 2025 Portfolio in Review

As of Q2 2025, Squarepoint held 5,235 positions worth $96.2B, up 17% from $82.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Squarepoint's Q2 2025 filing shows 767 new, 1,692 increased, 1,826 reduced and 817 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M. The largest sale was Microsoft, an estimated $1.48B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Squarepoint's largest Q2 2025 buy was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M.
  • Squarepoint added most to Amazon in Q2 2025, an estimated $410M increase.
  • Squarepoint's biggest Q2 2025 reduction was Microsoft, cutting an estimated $1.48B.
  • Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q2 2025, selling an estimated $194M.
  • Squarepoint's ten largest holdings make up 19% of its $96.2B portfolio in Q2 2025.
  • Squarepoint opened 767 new positions and closed 817 in Q2 2025.
  • Squarepoint's portfolio value rose 17% quarter-over-quarter to $96.2B.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.